Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.46
+0.18 (2.87%)
Oct 27, 2026, 2:59 PM EDT - Market open
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $195.45 million as of October 27, 2026. It is the 20,927th most valuable company in the world and the 3,609th biggest in the United States. Its market cap has decreased by 17.94% in one year.
Market Cap
195.45M
Enterprise Value
111.70M
1-Year Change
-17.94%
Global Rank
Country Rank
#3,609 United States
Category
ChartMarket Cap Chart
Since November 14, 2023, Cartesian Therapeutics's market cap has increased from $166.07M to $195.45M, an increase of 17.69%. That is a compound annual growth rate of 5.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 195.45M | 4.25% |
| Dec 31, 2025 | 187.49M | -59.31% |
| Dec 31, 2024 | 460.74M | 330.61% |
| Dec 29, 2023 | 107.00M | -35.57% |
| Nov 14, 2023 | 166.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 206.85M |
| Pyxis Oncology | 204.87M |
| Protalix BioTherapeutics | 203.04M |
| Korro Bio | 201.52M |
| Zentalis Pharmaceuticals | 197.86M |
| Eledon Pharmaceuticals | 190.75M |
| Alpha Cognition | 188.60M |
| Compugen | 184.71M |